Scientists have discovered a new drug target that could improve the effectiveness of radiation for hard-to-treat cancers. The finding focuses on the role of the enzyme cytosolic phospholipase A2 (cPLA2). This enzyme promotes development and functioning of blood vessel networks that feed malignant tumors, enabling them to overcome the effects of radiation.